Nsaid Usage
Nsaid Usage - Related Videos
11:02
Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
0 Views •
Cited by 1 •
2016
With the murine ABC transporter Bcrp1 (Abcg2) as an example, in-silico protocols are presented to detect alternative promoter usage in genes expressed in mouse tissues, and to evaluate the functionality of the alternative promoters identified using reporter assays.
07:06
Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
0 Views •
Cited by 16 •
2011
The prediction of the coreceptor usage of HIV-1 is required for the administration of a new class of antiretroviral drugs, i.e. coreceptor antagonists. It can be performed by sequence analysis of the env gene and subsequent interpretation through an internet based interpretation system (geno2pheno[coreceptor]).
10:22
MRM Microcoil Performance Calibration and Usage Demonstrated on Medicago truncatula Roots at 22 T
0 Views •
Cited by 3 •
2021
A protocol to study biological tissue at high spatial resolution using ultra-high field magnetic resonance microscopy (MRM) using microcoils is presented. Step-by-step instructions are provided for characterizing the microcoils. Finally, optimization of imaging is demonstrated on plant roots.
10:52
Design, Instrumentation and Usage Protocols for Distributed In Situ Thermal Hot Spots Monitoring in Electric Coils using FBG Sensor Multiplexing
0 Views •
Cited by 2 •
2020
This paper presents a protocol that enables instrumentation of random wound electric coils with fiber Bragg grating (FBG) thermal sensors for the purpose of distributed condition monitoring of internal thermal hot spots.
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
0 Views •
Cited by 14 •
2011
Basophil activation test is a potent tool for the detection of IgE-dependent allergies in vitro. Here, an optimized protocol for basophil activation test is used to investigate drug hypersensitivity. A method for the efficient production of covalent drug-protein conjugates and their physicochemical characterization is described.
FAQs
COX-1 and COX-2 inhibition changes prostaglandin production, but the consequences are not identical across treatment goals. Lower prostaglandin production can reduce pain, inflammation, and fever, while interference with COX-1-related protective and platelet functions contributes to gastrointestinal irritation or bleeding. This mechanism explains why symptom relief must be weighed against tissue protection and bleeding risk.
Drug selection, dose, and treatment duration determine how pharmacologic benefits are balanced against adverse effects. Appropriate planning aims to provide relief for pain, inflammation, or fever while limiting exposure associated with gastrointestinal irritation, bleeding, kidney injury, or cardiovascular complications. These decisions therefore form the basis of individualized, safety-conscious treatment rather than treating every indication identically.
Platelet effects are clinically important because NSAID-related changes can influence bleeding risk in addition to pain and inflammation. Gastrointestinal protection may also be reduced, helping explain why irritation and bleeding appear among the important adverse outcomes. In pharmacology, these effects are considered when balancing symptomatic benefit against treatment safety.
A practical NSAID usage plan links four decisions: select an appropriate medicine, choose a suitable dose, define the treatment duration, and monitor the patient. Monitoring is important because adverse effects may involve gastrointestinal irritation or bleeding, kidney injury, or cardiovascular complications. This structured approach supports symptom control while identifying safety concerns during treatment.
Clinical applications include musculoskeletal pain, arthritis, menstrual cramps, and acute injury, with fever also included among the symptoms these medicines can reduce. The relevant choice is not simply whether pain is present; pharmacologic use must also account for the intended therapeutic effect and the dose and duration needed to achieve it.
In pharmacology, NSAID usage illustrates how one enzyme pathway can produce both therapeutic and unwanted effects. Cyclooxygenase inhibition lowers prostaglandin production to support relief of pain, inflammation, and fever, yet it can also affect platelet function and gastrointestinal protection. Studying this balance helps explain why monitoring accompanies otherwise common treatment.